中国P站

Abstract

Schizophrenia research is making significant strides in understanding its complex etiology, driven by advances in genetics, neuro
biology, and environmental factors. Current therapeutic strategies emphasize personalized medicine, early intervention, and address
ing core symptoms like cognitive deficits and negative symptoms, crucial for functional outcomes. Neuroimaging studies continue to
refine our understanding of brain alterations and potential therapeutic targets. Emerging areas of interest include the role of inflam
mation, the gut microbiome, and social cognition deficits. Novel pharmacological agents, digital phenotyping, and early intervention
services are being explored to enhance treatment efficacy and monitoring. Psychoeducation remains a cornerstone of management,
with a growing emphasis on culturally sensitive programs.